New CKM guideline urges team-based care, yet UH data show major therapy gaps; CINEMA model boosts outcomes amid cost, trust, and handoff hurdles.
|Articles|August 1, 2000
Supplements and Featured Publications
- New Advances in the Treatment of Type 2 Diabetes: Clinical and Economic Implications for Managed Car
- Volume 6
- Issue 13 Suppl
CME/CPE Quiz
Advertisement
Articles in this issue
about 26 years ago
Participating Facultyabout 26 years ago
Introductionabout 26 years ago
The Clinical Implications of Insulin Resistanceabout 26 years ago
Selected Abstractsabout 26 years ago
BibliographyAdvertisement
Related to this article
Obesity care surges with GLP-1 demand, but fragmented ownership, prior authorizations, and coverage rules stall treatment—pharmacists step in.
Roundtables reveal HFpEF/HFmrEF care lags despite rising cases; learn new SGLT2/MRA strategies, screening, and scalable team pathways.
Advertisement
Advertisement